The multiple epitopes of oommon antigen on Salmonella flagellins were defined by a panel of monoclonal antibodies in Immunogold and Indireot Immunofluorescent test. This result was further verified by detecting these epitopes on the expression produot of flagellin gene fliC i in E. ooli Lc-2a. These common antigenio epitopes were different from that of serotypio H antigens. and they presented on flagellins of both phase 1 and phase II. The properties of these epitopes were assayed in SDS-PAGE. Western blotting, and ELISAs. The distribution of these epitopes was assessed by examining the binding patterns of each NAb to a set of 219 ~~Imonclla strains covering A through 0-67 serogroups and 96 other enteric baoteria including E. coli. Shigella. Citrobacter. Klebsiella. Proteus. Yersinia. Enterobacter and Serratia. It was found that these common epitopes showed the gener icccspecif iei ty of Salmonella. Furthermore. an EIA method was developed based on two NAbs CB8.de7 for detecting these epitopes on Salmonellae.The results of identification of 892 Salmonella isolates and detection of Salmonella oontamination from 10785 samples of food, feed and clinical specimens were coinoided well with oonventional oulture method. This showed that these oommon epitopes on Salmonella flagellin molecules could be used as a new recognized marker for the genus of Salmonella.
Adenoviruses are causative agents of acute respiratory infections as well as conjunctivitiS and gastroentheritis. In addition, adenoviruses have provided an excellent model system for the study of fundamental processes in eucaryotic cells and belng useful vectors for gene therapy. Monoclonal antibodies (Mabs) are very powerful tool for this research. We used human adenovirus type 4 (Ad4) as a model. It should note that this virus is of clinical significance being the cause of epidemic conjunctivitis. We obtained 23 hybridomas after fusion myeloma cells Sp2/0 with spleen cells from mice immunized with Ad4. Finally, 14 from them were selected for amplification as ascitic fluids. This ones were tested by dot inmunbbinding, immunofluorescence, radioimmunoprecipitation, ECL Western blotting, neutralization and passive haemagglutination. Our special interest was Mabs against capsid and core proteins.So, we obtained some Mabs which had strong binding with major capside protein, hexon. They shown diffuse nuclear fluorescence in Ad4 infected cells as well as in cells infected with Ad2 or Ad7. So, this ones have group cross-reactivity and it was also confirmed by immune precipitation with labelled cells infected with Ad4, Ad2, Ad7. The information on epitope mapping of the Ad4 hexon were received from Mabs competitive binding assay. For this purpose we developed the Simple, sensitive and rapid "a cOILpetitive avidin-biotin ECL dot-blot aS3ay". As a result we determined that Ad4 hexon molecule contain at least 2 different non-overlapping epitopes with group-specificity, and each contain 2 overlapping epitopes. We obtained also Mabs against internal core protein VII. This ones reacted with protein VII of the human adenoviruses type 2, type 5 (subgroup C), type 7 (subgroup B), type 10 (subgroup D) and type 4 (sub~roup E) of course but was not binding with Ad40 (subgroup F) and AdI2 (subgroup A). We used Mabs for examination of synthesis of the Ad4 virus polypeptides and epitope mapping. The last one for protein VII was realized partly by selection with Mabs of the active peptides from phage peptide library. The potential consensus sequence was ~IYX2PX3 which possible correspond sequence in Ad2 protein VII KNYTPT. The corresponding peptide was syntheSized and it was active in direct and competitive immunoassays. Thus this peptide represents the linear epitope in composition of the protein VII with group specificity. Functions of this one as well as other epitopes are under investigation now.
The Overexpression of the human epidermal growth factor receptor (EGFR) has been demonstrated in many human malignancies like squamous cell carcinoma of the head and neck, cervix, breast etc. which are most prevalent in India. This is often associated with poor prognosis and high mortality in these patients.
It has been reported that Monoclonal antibodies generated against EGFR which have the capacity to exhibit binding of ligands like EGF, TGF etc to their receptor have antitumor activity and hence great therapeutic application in the management of patients who do not respond to other treatment modalities like chemotherapy and endocrine therapy. In the case of breast tumors, Estrogen Receptor negative tumors have been found to be mostly EGFR positive. For these patients immunotherapy using specific antibodies directed to EGFR might prove to be of clinical value. One such Monoclonal antibody designated CIBCNSH3 has been generated in our laboratory which has been found to recognize an epitope in the extracellular domain of EGFR by immunoprecipitation and Western blot. By immunoperoxidase test, this antibody was found to exhibit strong reactivity to EGFR in head and neck cancers and breast cancers studied whereas with lymphoma cell lines like SUD6 and human lymphoma tissues, no staining was observed. This antibody inhibited the binding of EGF to its receptor on MDAMB 46B breast cancer cells rich in EGFR as revealed by competitive binding assay using 125 1 EGF indicating its antitumor activity.
In vitro studies performed using cell lines in culture like MDAMB 46B, HN5 etc with overexpression of EGFR revealed 90;1. cell death when incubated with the antibody. The in vivo therapeutic efficacy has been demonstrated by performing Tcg9m immunoscintigraphic studies on mice bearing these tumor xenografts before and after treatment with the monoclonal antibody. A total dose of 1.5 mg effected complete tumor regression which was also confirmed by histopathological studies. This monoclonal seems to have promising future application as therapeutic agent for tumors which overexpress EGFR. Little is known about the mechanism of self-assembly of the rnultienzyme system, in particular, of the role of Ela and El~ subunits in this processe. For the first time monoclonal antibody (rnAb) F7FIO against El component of PDe from pigeon breast muscle has been produced. The dissociation constant of the El-mAb complex was determined to be 59.3 nM. It was shown that mAb F7F10 cross reacted wi th E1 components of PDC from various species (including Escherichia coli and human) and did not react with other thiamine diphospha te dependent enzymes. The exi stance of highly conserved epitope common for pro-and eucaryotes indicates the essential role of the antigenic amino acid sequence which is unique for POCo The immunoblotting data showed that the wAb F7F10 interacted with both a and ~ subunits of E1. It suggests that amino acid residues of both subuni ts contribute to the antigenic determinant. This supposition is sustained by the fact that each isolated subunit also interacts wi th the wAb. It was shown that wAb F7F10 has no influence on E1 activi ty measured in model reaction with artificial electron acceptor. However it inhibited the full NAO and coenzyme A dependent activity of the whole POCo The competition of the F7F10 antibody with the E2 component of POC for the binding with E1 was revealed by immunoenzymatic and kinetic analysis. Thus mAb F7F10 is assumed to interact with an antigenic determinant, located in the immediate vicinity of or overlapping with the E1 region, responsible for E1-E2 interaction wi thin the POCo The data obtained suggest that while assembling native PDC it may be the E1~ subunit that binds to the E2 component. The formation of the antigen-antibody complex disturbs the E1-E2 interaction thus blocking the coordinated mechanism of catalysis. A number of severe human pathlogies are known to be due to congenital defect of E1 component of PDC. In this work mAb F7F10 was used to devise a model solid-phase immunoenzyme method for quantitative assay of E1 and POCo The detection limit of the method is 3.2 ng/ml for E1 and 79 ng/ml for PDC. Thus mAb F7F10 obtained can be used at least twofold: i) to locate and examine the contribution of various fragments of Ela and E1~ subunits to the formation of functional domains and to intersubuni t interaction areas, underlying the mul tienzyme complex formation; ii) on the other hand mAb obtained are useful when creating express-diagnostics for estimating concentrations of the complex components. The new conceptual model of immune response ( Titova 1Y96 in press) is presented. It includes basic propositions, part of which was known earlier but did not take into account, the other are postulated here: 1. Lymphocytes have information nesessary for a synthesis of antibodies to a majority of natural antigens, which induce derepression of cell genome and blasttransformation of cells. 2. According to the theory of polyvariance matrix processes in the cells the realization of genetic information may be different and dependent on the conditiQns~ That's why we assume that the Quality and the rate of the blast transformation depend on the dose of antigen included by each single cell (li~ited by the optimal range of doses). large doses induce rapid form~tlon ~f large blastcells with the corresponding phenotype and functIon, mIddle and small doses induce formation of middle and small blastcells, which appear after the larQe cell~ and have distinguishable phenotype and function. We suppose also that the blasttransformation is the reversible process during whicn lymphocytes become the memory-cells. 3, The suspensions of antigens (before and after the processing by the macrophages) are heterogeneous by the size of particles and consequently by the doses perceived by the cells. It results in different cells reactions and different rates of there exposian, in exponential increase of the number of sma~l blAstcells durri~g im~une response, sinc2 small doses usuaily dominate. We think, that the increase of the nJmber of the cells is not linked with cell division and the maturation of cells during immune response does not take place. 4. We suppose, that mechanisms of the contact antigendependend interaction cells during secondary response, restricted by ~HC I or MHC II antigens, are identical in the main. The difference betlllBen them is determined by functional state of the cells and their phenotype. The former leads to the lysis of the cells by the T , the last , as we assume, resulb in the fusion of Tb with B cells cor macrophages and fol10llling division of the polyplol.d forms, which leads to a formation the short-life end-plasmacells or the macrophages, which acquire new properties and morphology (granulomas cells). This hypothesis may become the key for the understanding of development mechanisms of immunodeficit state and pathogenesis of AIDS, for the ne~ understanding of llIechanisms of the immunity. It is known, t-hat the fusion is the property of the immunocompetent cells. Many data,which contradict the clonal selection theory,not only not contradict our model, but support it: 1) it may be an activation ~ith out proliferation,Z) conception of immature large blastcells inside ger~inal centres into less immature small cells is not evident,3)plasrna cells form a minority among antibody-secreting cells,4) hypermutations are not linked intimately with cell division and are prior to the en~ry that cell into a germinal centre, 5) the incre~se of.inclusian ~ thymidine is not compelling evidence of the prollferat1on of lymphocytes, 6) the phenotype Th and T is not constant property of the specialized cells, it may cHanQe. S In vitro production of human antisperm antibodies as probe of autoimmune response associated with immunological infertility Dimitrina K. Dimitrova-Dikanarova* Yoshiyuki Tsuji, Hiroaki Shibahara, Mizumi Mitsuo, Tomoko Hashimoto l and Koji Koyama Hyogo College of Medicine, Department of Obstetrics and Gynecology and I Department of Genetics, 1-1, Mukogawa -cho, Nishinomiya, Hyogo, 663, Japan A questions concerning the etiology of human infertility associated with antispenn antibody ( As-Ab ) production have been discussed for many years. The most important result from the development of isoimmune or autoimmune response against spenn antigens, due to a breakdown of sperm immune tolerance by different mechanisms, is manifested by As-Ab production. For these reasons, identification and analysis of antigens, recognized by As-Abs which interfere with fertilization, is the most important object in the study of the immunological infertility.
A strategy for obtaining human monoclonal antispenn antibodies using the method of Epstein-Barr Virus (EBV) transfonnation of peripheral blood lymphocytes (PBLs) from infertile women possessing high serum titers of spenn immobilizing antibodies (SI-Abs) , combined with 'pick-up' cloning method has been developed to investigate immunological infertility associated with sperm isoantigens. Using PBLs from 16 infertile patients with SI-Abs, we succeeded to obtain three stable cell populations (designated B 1. B2, DS) of transfonned PBLs originated from three different patients. They produced IgM SI-Abs directed against antigens expressed on the tail of live, methanol fixed and NaI04-treated human spelmatozoa.
The established As-Abs recognized non carbohydrate spenn membrane antigens with different specificity and distribution in male reproductive system. As-Ab B2 corresponding antigen seems to be specific for the male reproductive system. This antigen is excreted from the epithelial cells of ductus epididymidis and binds to the spennatozoa in the lumen of the ductus. As-Abs B I and D5 corresponding antigens were expressed on the spermatozoa in the seminiferous tubules and were common to the secretions of ductus epididymidis, prostate and some other somatic organs.
We are now attempting to obtain an infonnation concerning the DNA sequence of the variable region of human Ig heavy chain of the established As·Abs B 1, B2 and D5. This analysis will contribute to study the generation and diversity of As-Abs associated with human immunological infertility. Hybridoma technology has been most valuable in providing monoclonal antibodies to a variety of antigens, however the monoclonal antibodies generated are frequently of a class or subclass that is not optimal for the task to be performed. The type of monoclonal antibodies produced may vary according to the immunization protocol or to whether the antigen is T dependent or T independent. Antibody response to most T independent antigens consists largely of IgM antibodies of low affinity and does not show significant switching to other isotypes. When the isotype of the antibody is not suitable, immunoglobulin switch variants may be isolated. Using the ELISA spot assay we have been able to identify hybridoma' cells that have switched their isotype from one class to another. These rare isotype switch variants can be isolated using the sib selection approach described by Cavalli-Sforza and Lederberg for the isolation of bacterial mutants. The likelihood of recovery of spontaneous isotype switch variants is dependent on the frequency of switching events in vitro. Unlike spleen cells where switching can be enhanced and targeted to certain isotypes by cytokines, the fate of hybridoma cells depends on the spontaneous rate of switching of each clone. Frequencies of 1-5 per 105 cells or 1-10 per 107 are common among IgG1 and IgM secreting hybridoma cells respectively. These low frequencies require repeated steps of enrichment before final isolation can be achieved, or may fail to yield switch variants, either because switched cells are overgrown by the rest of the cells or die. Furthermore, when isotype switch variants are identified and isolated, they usually are of a certain isotype only. Attempts to enhance the frequency of switching ill vitro by cytokines such as IL-4, IFN-y or TGF-~ have been occasionally successful. A few hybridoma lines have switched at 35-50 fold higher frequency, while others were not affected. Due to the high cost of recombinant interleukins and the fact that the conditions required to stimulate hybridoma lines varies so much, we have tested the effect of a number of mutagens on the frequency of switching. Among the four mutagens tested, melphalan, mitomycin, ethylmethansulfonate and acridine orange (ICR), the last was the most consistently effective, increasing the frequency of switching by 5 to 50 fold. Antigen binding and fine specificity analysis as well as biological assays suggest that these antibodies maintain their binding and constant region sites intact. Recently tltere were published some data, which allow to suggest an inducting or aggravating role of hepatitis B virus during some forms of eye diseases (V.K.. Singh et al .• 1990; S.G. Robbins et al .• 1990 S.G. Robbins et al .• . 1991 S.G. Robbins et al .• . 1992 YN. Kushnir. 1992 ; R Achiron, 1994; O.S. Slepova, V.N. Kushnir et al .• 1995) .
INVESTIGATION OF HEPATITIS B VIRUS (BBV)
However. in connection witlt tlte wide spread of HBV -infection. traditional serodiagnosties is not informative enough when discovering HBVassociated ophtltalmopa1hology. Discoveries of HBV-markers in eye structures can be considered more convincing.
Using immunoferment analysis (ELISA). we examined HBV-markers (HBsAg and HBeAg; anti-HBs. anti-HBe. anti-HBc) in water-salt extracts of lens masses (n=66) and corneas (n-21). These samples were taken during tlte operation of cataract extraction from tlte following patients: 22 children aged from 6 mon1hs to 4 years witlt congenital cataracts; 23 adults aged up to 40 witlt complicated cataracts of unknown etiology; 11 persons aged from 60 to 72 years witlt senile cataracts; or during tlte keratoplasties operation (21 patients witlt corneal leucoma aged from 16 to 57). A1ltlte operated patients were residents of Moldova Republic. epidemiologically-unfavourable region in terms of HBVinfection Examination of lens masses showed tlte presence of HBe-Ag marker of active viral replication in 45% of samples. It was discovered mostly in children witlt congenital cataracts (62.5%) and in patients with complicated cataracts (75%). This marker was discovered seldom during senile cataracts (12.5%). Australian antigen -HBsAg-marker of active and chronic hepatitis B -was discovered in 34% of cases. It was mostly discovered in lens of patients witlt senile cataracts (87.5%); significantly less often it was discovered in young adults witlt complicated cataracts (35%) and in children witlt congenital cataracts. Antiviral antibodies (anti-HBc. anti-HBe and anti-HBs) characterizing different fases of infections process (including the postinfection immunil¥ stage) were discovered in 33%. 55%. 34% of samples correspondingly. Friquency of their discoveries variated from 18% to 100% during different cataract forms.
HBsAg was discovered in 8 from 21 (38%) corneal extract samples from patients witlt cornealleukomas.
I-IDeAg was discovered in 2 samples. which fact testifies an active virus replication.
We consider tlte discoveries of HBV-markers (especially of acute stage) in lenses and corneas of patients witlt cataracts and leucomas in testimony of a possible role ofHBV-virus as tlte reason oftltese eye diseases. S-antigen (S-Ag; 48 kDa) is the tissue-specific retinal protein with ability to induce the autoimmune reactions in human and anima1s (C. Pfister et al., 1985; Y. De Kozak et al., 1987; R. Nussenblattet al., 1989; O.S. Slepova, 1991) . We examined serum antibodies (ab) to S-Ag (S-IgM and S-IgG) in patients with IDDM without any of eye pathology and with different stages of diabetic retinopathy (DR). At the same time we examined concentration of TNF-a in serum. We also took in the account data about possible role of 1NF..a, in the mechanism of the autoimmune reactions development during IDDM (C.O. Jacob, 1992). We used enzyme linked immunosorbent .. say (ELISA).
EXAMINATION OF ANTmODIES TO RETINAL S-ANTIGEN AND TNF-a IN PATIENTS WITH INSULIN DEPENDENT DIABETES MELLITUS (IDDM
We examined 9 patients with primmy IDDM without DR, 23 patients with early stages of DR (DRO -II, DRI -12) and 58 patients with developed DR (DR2 -12, DR3 -46). The control group consisted of 16 practically healthy donors.
In control group TNF-a variated from 820 to 21oo pglmI; mean levels of S-IgM W88 0.7S±O.S8 • S-IgO 1.09±O.24. We foUnd that patients with primmy IDDM had tendency to increase ofTNF-a (12oo -3800 pglmI) and S-IgM level (1.33± 0.61) in comparison with the controls. Appearance of retinal changes (DRO and DRI) was associated with tendency to accumulation of S-IgO (1.Z4± 0.50) with simultaneous decrease of S-IgM level (0.99 ± 0.28) . During this stage there was discovered also a significant decrease of TNF-a in compariBon with primmy IDDM and with controls (p<O.OZ). In 80% of patients of those groups it was not higher than 140 -600 pglml. Development of pathologic process in retina (DR2 and DR3) was associated with haclcward increase ofTNF-a in compariBon with DRO and DRlstages (p<O.05). In 60% of patients its concentration variated from 540 to 64oo pglmI and had the tendency to exceed control parameters (p.; 0.05). In DR2 stage there was a tendency to haclcward increase of S-IgM level (1.3 ±O.7), the level of S-IgO remained comparatively high (1.25±O.5). Proliferative stage (DR3) was characterized by maximum levels of S-IgM (1.42±O.8) and S-IgO (1.4Z±O.3) in comparison with controls (p<0.02).
Therefore, we observed maximal increase of TNF -ct on the stages of primaIy IDDM and DR2 -DR3. In both cases the TNF-a level increase was combined with accumulation of serum S-IsM, cbamcterizing the primmy immune response, and preceded of the increase of S-IgO level which reflected the development of autoimmune reactions to S-Ag. It is characteristic that these peaks of the "immune activity" were noticed in periods antecedent to the appearence and aggravation of changes on the eye bottom.
These data allow to suppose that the increase of TNF -0< concentration in serum is a factor contributing to enhancing humoml Rutoimmune response induced by retinal S-Ag. Differentiated examination of serum S-IgM and S-IgG may be used in forecasting the development of prolifumtive DR.
Prevalence of CiTv-l'd and C~~IV-Total afltibod:l<;:!;~ in o.jl).Ll.l:,1it "'1.i_"i;11 Intensity anr dIstribution of immunohistochemical staining of molecular cell membrane markers depend on localization and the feature formi~ of tumor structure. So there is actual task to create the database about the results of immunological reactions of different reagents with the structure components of the tumor cells. We suggest that for each type of tissues or cells it should be determinated sufficient group of markers and part of cellular surface covered by these mark&rs. On the base of these data it is possible in the following to develop the classification characteristics of tumors.
In particular the offered approach should expose quite difinitely percent of "blank spaces" of membrane surface, which is occupied by not identified marker molecules. It can be "minor" or "major" markers, but a researcher should, at least, to have a opportuni ty to evaluate the areas, occupied by these markers.·
We .have shown the correctitude of thls .task on theeXaI/lple of experimental data. We have examined 'immunological reaction· of" mAbs ICO-25 with the· epi thelium of dHftrent localization tumors. We have found there are very much similar interaction of mAbs ICO-25 with epithelial cells of embrion and adult human, but between malignant and normal epithelium the considerable variations exist in the distribution of the antigen. Three types of reactions wi th the~1fferent intensity c:nd distribution of the label are distinctly manifasted.
Every type is characteristic of the definite group of tumors. It would follOW from the above that the prinCiple of oncodiagnosis must be based on the possibly largest number of onconosolog1cal un1ts and the attention should be drawn to the distribution and intenSity of the label. We believe that lectins on the surface tumor cells can find appllcation as diagnostic markers.
In perspective we believe to develop of diagnostic and classification methods. giving opportunities for the systemat1c costruction of the offered atlas. Each section of the atlas, connected with the cell and tissue discription for one or another desease. can include as a different microphotos. so sets of profiles and h1stogrames, obtained by flow cytometry. The goal of this investigation is to study the pathogenesis of progressive proliferative syndrome after repeated eye traumaproliferative vitreoretonapathy (PVR+. We used with immunohist6-chemical methods, monoclonal antibodies to Is: A,G,M; C1,CJ complement component, S-retinal antigen, liLA-DR antigen, adgesive glyC( . proteide-tlbronectlne. There were determined also T and B lymphocites. Fragmentes of epiretinal membranes from posttraumatic enucleated eyes (20) were matherial for the investigation. RESULTS. There were revealed the accumulatlom of immune depositos 01 Ig A,G; C1,C3 complement components in the epiretlnal membranes. There were determined T and B lymphocites among the cellular infiltration. We observed the expression of liLA-DR antigen by pigment epithelial cells, the S-retinal antigen and fibronectine were discovered in the eplretinal membranes. CONCLUSIONS. The data obtained confirmed the role of autoimmune disorders in posttraumatic PVR. It is possibl that the first perforative trauma of the eye accompanied with the autosensibilisation by ocular tissues. Due to this sensibilisation, the repeated surgical trauma, such as extraction of posttraumatic cataract, could lead to the development of autoimmune inflammation which pla1ed the l<ey role in the pathogenesis of PVR. • AO ''Biomash'', Moscow, Russia.
During the last time the interest to the using of monoclonal antibodies (McAb) as the instrument in diagnostic, therapy and immunoaffinity of different medical substances like digoxin, ~-interferon and others raised up. But the application of McAb from mouse ascit is limited because of the immunological reaction of human organism followed by the possible containing of mouse immuniglobulins and other proteins in preparats. So, one of the perspective way is seems to be the production of McAb in vitro, that allows to standardize and to control the production conditions. The necessary component of the media for cultivation of hybridoma is the fetal serum, which is become one of the limited factor in scale-up production of McAb because of the their high-costing and deficiency. So, it seems to us very actual the problem of the developing of serum-free media, as well as also the using of the complex of growth factors from sera and other sources instead of the fetal serum. This article is about the solving of these problems.
Using the hybridoma, producing McAb to digoxin, tumor necrose factor and several phytoviruses, we show the possibility and perspectivity of using of the medium with the supernatant of mieloma cells Ag K653X63 for the changing of medium with fetal serum. The exchanges of 10% of fetal sera on 1% of the last with 20% of supernatant media component allows to produce the same cell growth as in control. The total cell concentration was (1.8-25)"10 6 cell per milliliter. But the surviving of the cells in the novel medium was lower, like as 70-80%. Also, the possibility of serum-free cultivation of hybridoma, producing McAb to digoxin and~TNF, was shown. The serum-free media contains of the media IDMEM with the addition of specific components. The results of growth parameters of the suggested medium during 6 passages were the similar with the control and the antibody producing activity was more effective in serum-free variants. The interleukins play an important role in the development and maintenance of the immune system. Decreasell cell mediated immunity measures were found in schizophrenic patients. The purpose of the present study was to investigate the spontaneous, production of interleukin 1 (1L-3) and interleukin-3-like activity (IL-3-LA) by human mononuclear cells from schizophrenic patients compared to healthy individuals. IL-1 was significantly increased in schizophreniC patients as compared to controls. IL-3-LA was slightly elevated in schizophrenic patients as compared to controls. These findings support the hypotheSis of an autoimmune dysfunction in some schizophrenic patients. Mouse anti-endotheial cell mAb were raised by fusion of splenocytes separated from mice immuized with human AECA IgG fraction and mouse non-secrellng myeloma cells (NSO) using polyethylene glycol (PEG). Supernatants from growing hybridomas were screened for specific anllbody production by cyto-ELISA and FACS analysis using human or mouse endothelial celis. FollOWing the two fusions twelve clones were IdentHied as positive by Initial screening. Antibody fonnalion was stabilized following limiting dultion cloning In three of these clones (BGM, 3C8 and 7G2). The immunoreactivity of mAbs agalnsl panel of different antigens is shown in Singte chain Fv was prepared from two anti-cardiolipin and one anti-<:ardiolipinianti· DNA mouse monoclonal antibodies: 1) CAM (lgG) binds to CL, has lupus anti coagulant (LAC) activity and induces experimental APS In naive mice. 2) 2C4C2 ( IgM) binds to CL, DNA, reacts as LAC, and induces experimental APS associated with SLE. 3) CAL (lgG) binds to CL and Is non pathogenic In-vivo. The CAM and 2C4C2 uses the VH gene of the J558 family, while CAL uses the 7183 VH farnlly. All the three anti-cardiolipin monoclonal antibodies were converted into single chain Fv-s ( scFv·s) and showed the same ahtigen bindings properties as the original monoclonal antibodies, Replacement of the CAM VH domain with CAL VH decreases the binding avidity of the scFv to cardiolipin and completely abrogates the lupus anticoagulant activity ( did not prolong the APTT-activated thromboplastin time). Replacement of the pathogenic CAM VL wtth the non pathogenic CAL VL, did not affect the avidity for cardiolipin or the lupus anticoagulant activity.
NON PATHOGENICITY OF ANTI-DNA AND ANTI-PHOSPHOUPID ANT/aODlES IN IV/G PREPARATIONS

----------------------------------------------------
BALB/c mice were immuni2ed with the scFv domains of the three anti-cardiolipin antibodies and the scFv-s resulting from the replacement of the heavy and light chains. The mice Which were Immunized with CAM, 2C4C2 and CAL scFv-s, developed the same clinical manifestations, as the original mAbs ( e.g. elevated titers of mouse eCL and anti· phosphatydilserine antibodies foliowed by lupus anticoagUlant activity, thrombocytopenia, elevated APIT and high percentage of r:esorptions In Ihe CAM group. High titers of aCL. antissldsDNA were observed In the sera of the 2C4C2 scFv Immunized mice and the APS picture was associated with lupus findings: leukopenia, prolonged erythrocyte sedimentation rate and Immunoglobulin deposition In the kidneys. CAL scFv did not cause any clinical findings). The Idiotypic manipulation of naive mice has previously been used fot Induction of systemic eutoimmune diseases (eg. anti phospholipid syndrome, systemic lupus etylhematosus. Wegener's granulomatosis). The aim of this study focused on-the utilization of this technique to Induce the production of snti· endotheliel cells antibodies (AECA) and eutoimmune vaSCUlitis in a murine model. AECA were derived from a Wegener's granulomatosis patient plasma. IgO was purified by absorption on a proteinase-3 affinity column resulting In the depletion of antl-neutrophll cytoplasmic antibody activity. The absorbed IgO fraction displayed a high titer of AECA as evidenced by a cyto-ELISA against unfixed HUVEC. SALB/c mice were actively Immunized with the purified AECA. Three months after a boost injection with the human AECA, mice developed endogenous AECA (Ab3) but not antibodies to proteinasa·3. cardiolipin or DNA Histological examination of lungs and kidneys revealed both lymphoid cell Infiltration surrounding arterioles and venules 8S well 8S depOSition of immunoglobulins at the outer pari of blood vessel walls. This experimental animal model of vasculitis, 8 product of our method of Idiotypic manipUlation, has provided the first direct proof for the pathogenicity of AECA. K-antigen (Ag) is a surface-somatic glycoprotein (M.w. 55 kDa) which concentration correlates with the virulence of Salmonellas. We obtained 16 clones of hybrid cells secreting the monoclonal antibodies (MAb) to Salmonella typhimurium. MAb had different specifity, one of the clones showed high specifity to K-Ag in indirect Enzyme Linked Immunosorbent Assay «ELISA). The MAb specific for K-Ag of S.thyphimurium were IgG1"cappa". MAb specifically reacted with whole bacterial cells of S.typhi-murium, S. abortus bovi, S.stanley, S.choleraesuis, S.mission, S.london, S.cottbus, S. infantis, S. dublin, S. newport, S. gallinarum-pullorum, S. moscow, S.anatum and hadn't the cross-reactivity with antigenic structures of Escherichia coli, Proteus vulgaris, Citrobacter frandines, Enterobacter cloacae, Hafnia alvey, Shigella sonnei, Morganella morganii, Y. pseudotuberculosis in ELISA. Another clone had high specifity to purified O-Ag of S.typhimurium in ELISA. The MAb were IgG2a 'cappa', specifically reacted with whole bacterial cells of S. typhimurium and showed no activity to cells of Escherichia coli. According to the epitope analysis binding epitope of O-Ag contains the saccharine sequence abequosa-mannosa-rhamnosa. K-Ag determinants differed from O-Ag determinants. We can recommend the characterizated MAb for further study of antigenic structure and pathogenic .functions of Salmonellas.
IMMUNOPHENOTYPE OF PERIPHERAL BLOOD LYMPHOCYTES IN THE PATIENTS WITH OPHTHALMJTOXOPLASMJS1S L. Teplinskaya Moscow Helmholtz Research Institue of Eye Diseases, Russia
Purpose. To study the role of immunocompetent cells in pathogenesis of ophthalmotoxoplasmosis. Methods. Indirect immunofluorescence reaction on poly-L-l~sln with MKA ICO 1, 11, 12, 15, 20, 36, 40, 52, OKT8 for the determination of antigens la-, CD 11a, CD22, LFA-3, HNK-l, CD 38, RFB-l, CD1c,~-miCroglobulin, HLA-ABC, CD8. Results. 40 patients With toxoplasmosis uveitis were examined in acute (14), in subacute stage (15) and in remission (11). The studies showed that acute stage of uveitis had developed in deficiency of the cells, expressing la-, CD38 antigens, j3.irmiCrOgIObUline in 42, 9%, 57, 11:, 42, 9%, 2i ,4% of the patients accordingly. The number of CD22+ cells was increased in 35,7% of the patients, HNK-l' was increased in 46,2% and COle -in 23,1%. The defiCiency of CD8+cells was established in 42,9% of the patients and it was analogously to the changes in the blood of the patients Results. We styded 43 patiens with MS-caused during active phase (22) and remiSSion (2i) and 37 patients with ON other etiology during active phase (18) and remission (i9). In active phase of ON during MS the numbers of CD3+-and CD4+-cells remained unchanged. In 22.2% of patients CD8+-cells were deficiets. CD4+/CD8+coefficient was elevated in 36.4% of patients, possubly due to autoimmune component. Numbers of CD1'6+-cells were unchanged. Ma1n changes were found in 8-cells population: D-Iymphocytes and DR+-cells were deficient in 59% and 40.9% respectively. Remission was characterized by normalization of' CD4+-and CD4+/CD8+ coefficient. Number of CDi6+-cells remaind unchanged. In 47,6% of patients the diciency of 8-lymphocytes perSisted. During remission the numbers of CD4+-cells were restored, but the CD4+/CD8+ coefficient was decreased in 31,6% of patients. Contrary to patients with ON during MS, the patients with ON of other etiology during active phase or reccurence had the deficiency of CD4+-cells in 22,2% of cases. CD4+/CD8+ coefficient was increased 1n 22.7% of patients. Defficiency of CDi6+-cells and 8-lemphocytes was noted in 44 and 33.3% of patients respectively. During remission the number of CD4+-cells was restored. but the decrease of CD4+/CD8+ coefficient was noted in 3i.6% of patients. Deficiency of 8D16+-cells perSisted in 3i;6% of patients and the number of B-lymphocytes was lowered in 23.6% of patients. Lowering the number of DR+-cells was present in 3i.6% of patients.
Discussion. (MaAb) to different Bordetella pertussis antigens was obtained. A complex of antigens was isola1ed from B. pertussis cultivation medium by acidic precipi1ation. FHA, 92, 69, 65 ltD proteins, pertussis toxin subunits and LPS were detected in this complex by electrophoresis and immunoblotting with the use MeAb. After detoxication the complex exbibi1ed high immunogenic and protective activity and very low acute and chronic toxicity for mice. The monopreparations of acellular pertussis vaccine, made from the detoxified complex, as well as their mixture with diphtheria and te1anus toxoids, were adsorbed on aluminium hydroxide gel and lyophilized. The completeness and stability of the adsorption of antigens in the finished dried preparations were evalua1ed after adding water for injections by the analysis of superna1ants for the presence of free desorbed antigens in ELISA and electrophoresis with subsequent immunoblotting with the use of McAb to B. perlussis antigens and diphtheria toxoid. The conditions of antigen adsorption and lyophilization of acellular DTP vaccine, used in this process, ensured the firm and stsble binding of all antigens con1ained in this vaccine with its protective activity being preserved for at least 3 yean. The sensitivity of the antigen determination with the use of McAb was 0.002 U/ml for diphtheria toxoid, 5-15 ng for B. pertussis proteins in immunoblotting and 8 ng/ml for LPS. The values of international protective units for the pertussis component of lyophilized acellular DTP vaccine were higher than those of the pertussis component of commercial whole-cell DTP vaccine. The study of mechanisms of in vitro immune response, the choice of optimal conditions for its stimulation with antigens of different nature present good prospects for ob1aining immune lymphocytes for use in hyhridoma technology, and particularly for obtaitting .cells prod!.lCing hUIII8ILimmunogiol!ullns. We fa.iled to induce ill v(tro antibody synthesis in the nonfractionated mixture of $Pleen cells with ari' iddefinite number of macrophages (MP) of BALB/ c mice. The antigen in combination with some polyc1onal activators was found to alter the composition of the responding cell population. After adding the definite number of MP, previously incubated for 24 hours with different doses of killed P. pseudomallei cells, we found out that at the presence of the maxima1 dose of the antigen in the MP cultore (2 IOU/mI) and in the mixtore with B cells (0.64 IOU/mI) resulted in the death of the cells and the absence antibodies by day 6 of cultivation. With the dose of P. pseudomal1ei cells equal to 0.05 IOU/mI in the MP culture and 0.016 IOU/mI in the B cell cultore after the addition of MP, the highest total survival rate of cells (64 %), the least total amount of MP (2.8%) and the most intensive synthesis of anti-Pseudomonas Ab (1:64 in ELISA) were noted by day 6 of cultivation. At moderate doses of the antigen the number of cells increased with MP constituting 30 % of the number of live cells; antibody synthesis was twice as low. Polyclonal activators, when added on day 2 of cultivation at the presence of the antigen, produced the following changes: The highest Ab synthesis the minimal increase of the total number of cells (I.7-fold) and MP (4-fold) were noted in the culture with PHA added. The lowest Ab synthesis (1:2 in ELISA), the increase of the total number of cells (3.S-fold) and the number of MP (29-fold) were noted after the addition of ConA. Thus under certain conditions P. pseudomallei antigen induced the proliferation of MP, leading to their domination, and the suppression of Ab synthesis. Some mitogens enhanced this effect. At the minimal doses of the antigen and the moderate content of MP we could induce primary immune response to P. pseudomaJlei cells in vitro. These data are of interest for the development of schemes of in vitro immunization. They may also be useful for the study of the pathogenesis of melioidosis, often leading to the development of granulomas which consist, to a great extent, of macrophagal elements.
INDUCTION OF CHANGES IN THE COMPOSITION OF CELL POPULATION WITH PSEUDOMONAS PSEUDOMAlLEI
Immunotoxins based on antimelanoma monoclonal antibodies B3F7 and ricin A-chain or riCinus agglutinin A-chain. Moisenov ich M. M., Egorova S. G., Maluchenko N. V., Tonev isky A. G ..
MoscoII' MV Lomonosov State 'lr(1v, Sch Bioi, Dept Cell Physiology & Immunology, Moscow 119B99, Russia.
Murine monoclonal antibodies (mAbs) B3F7 have been obtained. These mAbs react with melanoma cell lines, with freshly isolated melanoma cells and stain melanoma parafin tissue section. The antibodies do not react with PBL, tested normal adult and fetal tissues (10 specimens) and with tumours (]ung adenocarCinoma, breast cancer, sarcomas). It was shown also by immunofluorescent method, that antigen, identified by monoclonal antibodies B3F7, localized on cell membrane. The Mr of antigen recognized by mAbs B3F7 is abou t 35 kOa.
Monoclonal antibodies B3F7 have been chemically conjugated to riCin toxin A-chain (RTA) and to riCinus agglutinin A-chain (AGA). Data from indirect immunofluorescence assay on cells ' MeWo and A9 demonstrated specificity and immunoreactivity of the RTA/B3F7 and AGA/B3F7 immunotoxins, which was identical to that of native antibodies B3F7.
Antigen-negative A9 (murine fibroblasts) cells incubated for 72 hours with immunotoxins showed no increased cytotoxicity compared with A9 cells exposed to A-chains alone. However, the immunotoxins was toxic to antigen-posi tive MeWo and MS cells. RTA/B3F7 and AGA/B3F7) immunoconjugates killed MeWo melanoma cells (LD50 2-10(-9) M and 10(-B) M). Various lysosomotropic agents augmented immunotoxins cytotoxiCity. Monensin and NH4CI, when combined with both immunotoxins, augmented their cytotoxicity more than 10-fold.
The antigen recognized by mAb B3F7 may be used as a target for immunotherapy of human melanoma. The commercial preparations of ti •• ue culture media were found to be contaminated with bacterial catabolic products (BCP) with metal-bindina capClci ty .. Accordin2 to dat,,_,preeent!l!'h ~l,s~lfh",;-e BCP are ready of binding to the proteins produced by the methods of cell biotechnology includina the hybridomaB deriving monoclonal antibodies -NAb (A.J.Kulbo::rg et a1., 1994-95).
Here we describe a general principle for elimination of BCP admixture from MAb by using insolubilized natural metal-scavengering substance with well establi.hed origin and structure (termed AV-23). Passage of the commercial MAb preparations throuah a oolumn with insolubilized AV-23 resulted in purification NAb from BCP, as tested with specific anti-BCP ro::~ent, followed by a significant increase 1n NAb reactivity to speoific ant1gens showed in indirect ELISA.
Data obtained may imply that BCP induce the conformational rearrangement within the antibody molecule with at least partial blccking the antibody active sites, Therefore, the technology offered can be usefUl in manufacturing MAb preparations applied for different diagnostic assays,
